AirwaysCARE Forum – Berlin 2026

On September 15, 2026, AirwaysCARE will launch its inaugural event in Berlin, marking the beginning of a new international network dedicated to collaboration, education, and innovation in airway and allergy care.

Set in the unique and historic Lecture Hall Ruin of the Berlin Museum of Medical History at the Charité, the event brings together leading experts, early-career researchers, and healthcare professionals in an inspiring environment that connects past and future medical practice.

Designed as a hybrid experience, the event will welcome up to 70 participants onsite in Berlin, while additional AirwaysCARE centres can join virtually from across the network.

A Day of Exchange and Insight

The program combines concise scientific input with open, interactive discussion. A series of high-impact keynote mini-lectures will highlight the latest developments in research and clinical practice in airway and allergy diseases.

These sessions will lead into an interactive “Fireside Talk” – a moderated, conversation-style discussion designed to encourage dialogue, questions, and the exchange of real-world experiences. The format emphasizes practical insights, career perspectives, and shared learning in a relaxed, informal setting.

The program combines concise scientific input with open, interactive discussion. A series of high-impact keynote mini-lectures will highlight the latest developments in research and clinical practice in airway and allergy diseases. These sessions will feature internationally renowned experts, including Prof. Dr. Giorgio Walter Canonica and Prof. Dr. Dr. h.c. Torsten Zuberbier, who will share their perspectives and set the stage for deeper exchange throughout the day.

Preliminary Scientific Programme

The scientific programme will focus on cutting-edge developments in asthma and airway allergies, covering novel disease mechanisms, emerging therapeutic targets, and innovative treatment approaches. Through expert presentations and interactive discussions, participants will gain insights into current challenges and future directions in airway disease management, while exploring opportunities for collaboration within the AirwaysCARE network.

Session
Opening SessionWelcome & Introduction to GA²LEN AirwaysCARE in collaboration with ARIA
Scientific Session IThe Role of TSLP in Asthma and Airway Allergies
Scientific Session IIThe Implementation of Type 2 (T2) Inflammation Concepts in Asthma and Airway Allergies
Scientific Session IIIThe Role of Systemic JAK Inhibitors in Airway Allergies
Scientific Session IVBeyond IgE: The Role of X2 Receptors and Neuro-Immune Interactions
Scientific Session VNovel Treatment Concepts for Upper Airway Allergies and Ocular Involvement
Interactive SessionFireside Talk: Practical and Clinical Aspects of the AirwaysCARE Network

Building Connections that Matter

Beyond the scientific program, the event places strong emphasis on meaningful networking. Participants will have the opportunity to engage directly with key opinion leaders and peers in an intimate setting that fosters open conversation and collaboration.

As a pilot event, AirwaysCARE Berlin 2026 is intentionally designed as an intimate and highly interactive experience. It lays the foundation for future expansion, with plans to grow the network, increase participation, and further develop the format in the years to come.

Supporting the Next Generation

A core focus of the AirwaysCARE initiative is to support early-career professionals. The event offers young researchers and clinicians a platform to learn, connect, and become part of a growing international community from an early stage in their careers.

Interdisciplinary and Patient-Centred

The event welcomes professionals from across disciplines, including pulmonology, allergy and immunology, dermatology, pediatrics, and otolaryngology. Patient organizations may also be involved, contributing valuable real-world perspectives and helping to strengthen patient-centred care.

Registration

Registration for the AirwaysCARE Event Berlin 2026 will open soon. Further details on participation and access to the hybrid sessions will be announced shortly.